GGrantIndex
Sort

23,748 grants matching melanoma

Engaging and Enhancing Neuroblastoma Immune Targeting

$173,248
John M Maris · Children'S Hosp Of Philadelphia · U54 · FY2021 · CA

Feedback regulation and functional output of the RAS/RAF/MEK/MAPK pathway in huma

$173,232
Christine Anne Pratilas · Sloan-Kettering Inst Can Research · K08 · FY2010 · CA

Feedback regulation and functional output of the RAS/RAF/MEK/MAPK pathway in huma

$173,232
Christine Anne Pratilas · Sloan-Kettering Inst Can Research · K08 · FY2012 · CA

Feedback regulation and functional output of the RAS/RAF/MEK/MAPK pathway in huma

$173,232
Christine Anne Pratilas · Sloan-Kettering Inst Can Research · K08 · FY2009 · CA

Feedback regulation and functional output of the RAS/RAF/MEK/MAPK pathway in huma

$173,232
Christine Anne Pratilas · Sloan-Kettering Inst Can Research · K08 · FY2011 · CA

Epidemiology

$173,147
Andrew Olshan · Univ Of North Carolina Chapel Hill · P30 · FY2015 · CA

Interrogating inflammatory responses to SARS-CoV-2 infection in vivo

$173,137
Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Isolation, Characterization, and Behavior of Melanocyte Stem Cells

$173,114
Thomas J Hornyak · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Molecular Genetics of Melanoma

$173,086
Hensin Tsao · Massachusetts General Hospital · K24 · FY2015 · CA

Adhesion GPCR interactome landscaping by in vivo biotinylation proteomics

$173,031
Xianhua Piao · University Of California, San Francisco · R21 · FY2018 · NS

The role of the novel interface cell state in melanoma invasion

$173,016
Miranda Victoria Hunter · Sloan-Kettering Inst Can Research · K99 · FY2024 · CA

The role of the novel interface cell state in melanoma invasion

$173,016
Miranda Victoria Hunter · Sloan-Kettering Inst Can Research · K99 · FY2023 · CA

Biostatistics

$172,998
Michael Joseph Schell · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2015 · CA

Core D: Animal Experimentation & Wound Healing

$172,985
Kevin D Cooper · Case Western Reserve University · P30 · FY2012 · AR

Biostatistics

$172,972
Michael Joseph Schell · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2014 · CA

The unique role of B-Raf in murine cardiac development and postnatal function

$172,812
Natasha N Chattergoon · Oregon Health & Science University · K01 · FY2016 · HL

The unique role of B-Raf in murine cardiac development and postnatal function

$172,812
Natasha N Chattergoon · Oregon Health & Science University · K01 · FY2017 · HL

Gene Discovery in Melanoma Etiology

$172,794
Timothy R Rebbeck · Wistar Institute · P50 · FY2006 · CA

Biostatistics

$172,760
Michael Joseph Schell · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2016 · CA

Disparate suppression of naive effector and memory T cells in tumor-bearing hosts

$172,688
Jose Alejandro Guevara-Patino · University Of Chicago · R21 · FY2009 · CA

Validation of genomic targets in melanoma

$172,590
Mohammed Kashani-Sabet · University Of California, San Francisco · R01 · FY2009 · CA

Differentiation Therapy of Uveal Melanoma Micrometastases

$172,462
Pierre L Triozzi · Wake Forest University Health Sciences · R21 · FY2014 · CA

Coded-aperture Compton scatter imaging for real-time tumor motion tracking during ablative radiotherapy

$172,460
Bernard L Jones · University Of Colorado Denver · R21 · FY2021 · CA

Obesity increased cancer risk by NKT cell depletion (PQ1)

$172,456
Mark A Exley · Brigham And Women'S Hospital · R21 · FY2013 · CA

Low dose interleukin 2 for the expansion of regulatory T cells and the treatment of moderate to severe ulcerative colitis

$172,413
Scott B Snapper · Boston Children'S Hospital · R21 · FY2019 · DK